Saeki T - Search Results

1

Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer.

Watanabe J, Ito Y, Saeki T, Masuda N, Takano T, Takao S, Nakagami K, Tsugawa K, Nakagawa S, Kanatani K, Nakayama T. Watanabe J, et al. Among authors: saeki t. In Vivo. 2017 May-Jun;31(3):493-500. doi: 10.21873/invivo.11088. In Vivo. 2017. PMID: 28438884 Free PMC article. Clinical Trial.

2

[A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].

Sano M, Tokuda Y, Noguchi S, Aogi K, Saeki T, Tabei T, Hatake K, Fujii H. Sano M, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2006 Aug;33(8):1091-7. Gan To Kagaku Ryoho. 2006. PMID: 16912527 Clinical Trial. Japanese.

3

Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.

Saeki T, Nomizu T, Toi M, Ito Y, Noguchi S, Kobayashi T, Asaga T, Minami H, Yamamoto N, Aogi K, Ikeda T, Ohashi Y, Sato W, Tsuruo T. Saeki T, et al. J Clin Oncol. 2007 Feb 1;25(4):411-7. doi: 10.1200/JCO.2006.08.1646. Epub 2006 Dec 18. J Clin Oncol. 2007. PMID: 17179098 Clinical Trial.

4

Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.

Shigekawa T, Takeuchi H, Misumi M, Matsuura K, Sano H, Fujiuchi N, Okubo K, Osaki A, Aogi K, Saeki T. Shigekawa T, et al. Among authors: saeki t. Breast Cancer. 2009;16(1):88-92. doi: 10.1007/s12282-008-0056-x. Epub 2008 May 14. Breast Cancer. 2009. PMID: 18478315

5

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: saeki t. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

6

Evaluation of the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancer.

Saeki T, Noguchi S, Aogi K, Inaji H, Tabei T, Ikeda T. Saeki T, et al. Ann Oncol. 2009 May;20(5):868-73. doi: 10.1093/annonc/mdn714. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150935 Free article. Clinical Trial.

7

The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype.

Aogi K, Yoshida M, Sagara Y, Kamigaki S, Okazaki M, Funai J, Fujimoto T, Toi M, Saeki T, Takashima S. Aogi K, et al. Among authors: saeki t. Cancer Chemother Pharmacol. 2011 May;67(5):1007-15. doi: 10.1007/s00280-010-1390-1. Epub 2010 Jul 14. Cancer Chemother Pharmacol. 2011. PMID: 20628744 Clinical Trial.

8

Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study.

Takao S, Tokuda Y, Saeki T, Funai J, Ishii M, Takashima S. Takao S, et al. Among authors: saeki t. Breast Cancer. 2012 Oct;19(4):335-42. doi: 10.1007/s12282-011-0289-y. Epub 2011 Jul 13. Breast Cancer. 2012. PMID: 21751001 Clinical Trial.

9

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.

Toi M, Saeki T, Iwata H, Inoue K, Tokuda Y, Sato Y, Ito Y, Aogi K, Takatsuka Y, Arioka H. Toi M, et al. Among authors: saeki t. Breast Cancer. 2014 Jan;21(1):20-7. doi: 10.1007/s12282-012-0344-3. Epub 2012 Mar 2. Breast Cancer. 2014. PMID: 22382811 Clinical Trial.

10

A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.

Suzuki Y, Saeki T, Aogi K, Toi M, Fujii H, Inoue K, Watanabe T, Fujiwara Y, Ito Y, Takatsuka Y, Iwata H, Arioka H, Tokuda Y. Suzuki Y, et al. Among authors: saeki t. Int J Clin Oncol. 2013 Aug;18(4):590-7. doi: 10.1007/s10147-012-0421-9. Epub 2012 May 15. Int J Clin Oncol. 2013. PMID: 22585426 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

753 results

Search Page

Filters